Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

NCT03542851 is registered in ClinicalTrials.gov with Balance Therapeutics as lead sponsor.

NCT NCT03542851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Lead sponsor
Balance Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
May 29, 2018
Completion date
May 28, 2020
Enrollment
80 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic hypersomnia